Feedback / Questions
narsoplimab (OMS721) - Omeros
https://www.fiercebiotech.com/biotech/fda-delays-omeros-2nd-attempt-transplant-drugs-approval-3-months?utm_medium=email&utm_source=nl&utm_campaign=LS-NL-FierceBiotech&oly_enc_id=7454A1965223C2B
Aug 15, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next